Literature DB >> 33498191

The Resistance to Host Antimicrobial Peptides in Infections Caused by Daptomycin-Resistant Staphylococcus aureus.

Md Saruar Bhuiyan1, Jhih-Hang Jiang1, Xenia Kostoulias1, Ravali Theegala1, Graham J Lieschke2, Anton Y Peleg1,3.   

Abstract

Daptomycin is an important antibiotic for the treatment of infections caused by Staphylococcus aureus. The emergence of daptomycin resistance in S. aureus is associated with treatment failure and persistent infections with poor clinical outcomes. Here, we investigated host innate immune responses against clinically derived, daptomycin-resistant (DAP-R) and -susceptible S. aureus paired isolates using a zebrafish infection model. We showed that the control of DAP-R S. aureus infections was attenuated in vivo due to cross-resistance to host cationic antimicrobial peptides. These data provide mechanistic understanding into persistent infections caused by DAP-R S. aureus and provide crucial insights into the adaptive evolution of this troublesome pathogen.

Entities:  

Keywords:  S. aureus; antimicrobial peptides; daptomycin; persistent infection

Year:  2021        PMID: 33498191     DOI: 10.3390/antibiotics10020096

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


  4 in total

Review 1.  The Influence of Antibiotic Resistance on Innate Immune Responses to Staphylococcus aureus Infection.

Authors:  Nazneen Jahan; Timothy Patton; Meredith O'Keeffe
Journal:  Antibiotics (Basel)       Date:  2022-04-19

2.  High Incidence of Acute Kidney Injury in Patients Treated with High-Dose Amoxicillin and Cloxacillin Combination Therapy.

Authors:  Yvon Ruch; Axel Ursenbach; François Danion; Fanny Reisz; Thierry Nai; Baptiste Hoellinger; Yves Hansmann; Nicolas Lefebvre; Jonas Martzloff
Journal:  Antibiotics (Basel)       Date:  2022-06-04

Review 3.  Zebrafish: An Attractive Model to Study Staphylococcus aureus Infection and Its Use as a Drug Discovery Tool.

Authors:  Sari Rasheed; Franziska Fries; Rolf Müller; Jennifer Herrmann
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-21

4.  Combination of Amphiphilic Cyclic Peptide [R4W4] and Levofloxacin against Multidrug-Resistant Bacteria.

Authors:  Muhammad Imran Sajid; Sandeep Lohan; Shun Kato; Rakesh Kumar Tiwari
Journal:  Antibiotics (Basel)       Date:  2022-03-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.